文献速递瘢痕与激光创面修复

瘢痕疙瘩患者外周血纤维细胞水平及CXCL12表达上调

Systemic Fibrocyte Levels and Keloid Expression of the Chemoattractant CXCL12 Are Upregulated Compared With Patients With Normal Scar.
PubMed 文献 · Ann Plast Surg · 2021-01-01

该研究比较了瘢痕疙瘩患者与正常瘢痕形成者的外周血纤维细胞(CD45+、Col I+)数量及CXCR4/CXCL12轴表达。结果显示瘢痕疙瘩患者循环纤维细胞显著增多(17.4×10^5 cells/mL vs 1.01×10^5 cells/mL,P=0.004),表达CXCR4的纤维细胞绝对数亦显著增加(P=0.012),且瘢痕疙瘩局部CXCL12表达显著高于正常瘢痕(529.3 pg/mL vs 检测不到)。提示该生物学轴可能参与瘢痕疙瘩形成及复发。

要点

  • 瘢痕疙瘩患者外周血纤维细胞数量显著高于正常瘢痕者
  • 瘢痕疙瘩局部CXCL12表达显著上调,正常瘢痕检测不到
  • CXCR4/CXCL12轴可能参与瘢痕疙瘩形成与复发

核心结论

  • 瘢痕疙瘩患者全身纤维细胞水平及负责纤维细胞向局部纤维化区域迁移的CXCR4/CXCL12生物学轴均上调。
  • 瘢痕疙瘩持续表达CXCL12,后者既是纤维细胞主要趋化因子也是局部炎症下游介质,提示该轴在瘢痕疙瘩形成及可能复发中起作用。

研究设计与样本

  • 研究纳入长期瘢痕疙瘩患者与形成大体正常瘢痕者,采集血液标本。
  • 采用荧光激活细胞分选分析纤维细胞(CD45+、Col I+),并比较CXCR4表达、pSMAD2/3及血浆CXCL12水平。
  • 切除瘢痕疙瘩与大体正常瘢痕标本,检测局部CXCL12表达。

主要发现

  • 瘢痕疙瘩形成者循环纤维细胞数显著高于对照(17.4×10^5 cells/mL vs 1.01×10^5 cells/mL,P=0.004)。
  • 瘢痕疙瘩形成者表达CXCR4的纤维细胞绝对数显著更高(P=0.012)。
  • 瘢痕疙瘩形成者全身CXCL12水平较对照升高但差异无统计学意义。
  • 瘢痕疙瘩标本CXCL12表达显著高于正常瘢痕(529.3 pg/mL vs 检测不到)。

临床怎么用

  • 外周血纤维细胞计数及CXCR4/CXCL12轴表达可能作为瘢痕疙瘩风险评估的参考指标。
  • 靶向CXCL12趋化轴或可为减少瘢痕疙瘩形成及复发提供潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibrocytes are bone marrow mesenchymal precursors with a surface phenotype compatible with leukocytes, fibroblasts, and hematopoietic progenitors that have been shown to traffic to wound healing sites in response to described chemokine pathways. Keloids are focal fibrotic responses to cutaneous trauma characterized by disordered collagen, which may be associated with elevated systemic fibrocyte levels and/or wound bed chemokine expression. METHODS: Blood specimens from patients with longstanding keloids and those who form grossly normal scars were assayed by fluorescence activated cell sorting analysis for fibrocytes (CD45+, Col I+). The expression of the fibrocyte chemotactic cell surface marker CXCR4, intracellular markers of fibroblast differentiation (pSMAD2/3), and plasma levels of the CXCR4 cognate CXCL12 were compared. Keloid specimens and grossly normal scars were excised, and local expression of CXCL12 was assayed. RESULTS: Keloid-forming patients demonstrated a significantly greater number of circulating fibrocytes (17.4 × 105 cells/mL) than control patients (1.01 × 105 cells/mL, P = 0.004). The absolute number of fibrocytes expressing CXCR4 was significantly greater (P = 0.012) in keloid-forming patients. Systemic CXCL12 levels were insignificantly greater in keloid-forming patients than controls. Keloid specimens had significantly greater CXCL12 expression (529.3 pg/mL) than normal scar (undetectable). CONCLUSIONS: Systemic fibrocyte levels and the CXCR4/CXCL12 biologic axis responsible for fibrocyte trafficking to areas of regional fibrosis were both upregulated in patients who form keloids compared with controls. Keloids persistently expressed CXLC12, which serves both as the main chemoattractant for fibrocytes and a downstream mediator for local inflammation, suggesting a role for this biologic axis in keloid formation and possibly recurrence.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Campbell CA, Burdick MD, Strieter RM, et al. Systemic Fibrocyte Levels and Keloid Expression of the Chemoattractant CXCL12 Are Upregulated Compared With Patients With Normal Scar. Ann Plast Surg. 2021. PMID: 34253698. doi:10.1097/SAP.0000000000002929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。